LA
BMY icon

Leonetti & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Leonetti & Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-91,250
Closed -$4.92M – 35
2016
Q3 		$4.92M Sell
91,250
-4,700
-5% -$302K 1.39% 24
2016
Q2 		$7.06M Buy
+95,950
New +$6.78M 2.02% 20

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Leonetti & Associates's BMY Position: Q4 2016 in Review

Leonetti & Associates sold out of Bristol-Myers Squibb (BMY) in Q4 2016, closing a stake of 91,250 shares — an estimated $4.92M sold.

Leonetti & Associates first reported a position in BMY in Q2 2016 and held it in 2 quarters. The position peaked at $7.06M in Q2 2016. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

  • Leonetti & Associates reported no remaining Bristol-Myers Squibb position as of Q4 2016 after selling out during the quarter.
  • Leonetti & Associates sold 91,250 Bristol-Myers Squibb shares in Q4 2016, an estimated $4.92M.
  • Leonetti & Associates first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 2 quarters.
  • Leonetti & Associates's Bristol-Myers Squibb position peaked at $7.06M in Q2 2016.
  • 1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on Leonetti & Associates's 13F filing for Q4 2016, filed 15 Feb 2017.